6-[7-acetyl-2-(4-fluorophenyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide
C22H19FN6O2 — CID 122510904
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[7-acetyl-2-(4-fluorophenyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide
6-[7-acetyl-2-(4-fluorophenyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide (PubChem CID 122510904) has the molecular formula C22H19FN6O2 and a molecular weight of 418.43 g/mol. Its IUPAC name is 6-[7-acetyl-2-(4-fluorophenyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | 6-[7-acetyl-2-(4-fluorophenyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 122510904 |
| Molecular Formula | C22H19FN6O2 |
| Molecular Weight | 418.43 g/mol |
| Exact Mass | 418.16 |
| IUPAC Name | 6-[7-acetyl-2-(4-fluorophenyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide |
| SMILES | CC(=O)N1CCn2c(nc(-c3ccc(F)cc3)c2-c2ccc3ncc(C(N)=O)n3c2)C1 |
| InChI | InChI=1S/C22H19FN6O2/c1-13(30)27-8-9-28-19(12-27)26-20(14-2-5-16(23)6-3-14)21(28)15-4-7-18-25-10-17(22(24)31)29(18)11-15/h2-7,10-11H,8-9,12H2,1H3,(H2,24,31) |
| InChIKey | YVYOKWAPEVPPGT-UHFFFAOYSA-N |
| XLogP | 2.46 |
| TPSA | 98.52 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 418.43 |
| LogP ≤ 5 | 2.46 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122510904 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.